Share on StockTwits

Agile Therapeutics (NASDAQ:AGRX) major shareholder Ab Investor purchased 1,000,000 shares of the company’s stock in a transaction that occurred on Thursday, May 22nd. The stock was purchased at an average cost of $6.00 per share, with a total value of $6,000,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Agile Therapeutics (NASDAQ:AGRX) traded up 0.18% on Tuesday, hitting $5.55. The stock had a trading volume of 289,985 shares. Agile Therapeutics has a 52-week low of $5.05 and a 52-week high of $6.06. The stock has a 50-day moving average of $5.5 and a 200-day moving average of $5.5. The company’s market cap is $103.2 million.

Agile Therapeutics, Inc is a women’s health specialty pharmaceutical company. The Company focused on the development and commercialization of new prescription contraceptive products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.